ADMA vs VRTX: Which Stock is Better?
Side-by-side comparison of Adma Biologics Inc and Vertex Pharmaceuticals Inc in 2026
ADMA
Adma Biologics Inc
$15.39
VRTX
Vertex Pharmaceuticals Inc
$456.69
Key Metrics Comparison
| Metric | ADMA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $3.67B | $116.00B | VRTX |
| P/E Ratio | 25.65 | 30.12 | ADMA |
| EPS (TTM) | $0.60 | $15.16 | VRTX |
| Revenue Growth | 0.2% | 0.1% | ADMA |
| Gross Margin | 57.4% | 53.7% | ADMA |
Analyze ADMA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADMA or VRTX a better investment?
Comparing ADMA and VRTX: Adma Biologics Inc has a market cap of $3.67B while Vertex Pharmaceuticals Inc has $116.00B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADMA and VRTX?
ADMA (Adma Biologics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADMA or VRTX?
Based on P/E ratios, ADMA trades at a lower multiple (25.6x vs 30.1x).
Which is growing faster: ADMA or VRTX?
ADMA has higher revenue growth at 0.2% vs 0.1% for VRTX.
Which company is more profitable: ADMA or VRTX?
Adma Biologics Inc (ADMA) has higher gross margins at 57.4% compared to 53.7% for VRTX.
Which is the larger company: ADMA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $116.00B compared to $3.67B for ADMA.
Should I buy ADMA or VRTX in 2026?
Both ADMA and VRTX have investment merit. ADMA trades at $15.39 while VRTX trades at $456.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADMA and VRTX stock?
Key differences: Market Cap ($3.67B vs $116.00B), P/E Ratio (25.6x vs 30.1x), Revenue Growth (0.2% vs 0.1%), Gross Margin (57.4% vs 53.7%).